Hyderabad Telangana, India

Nelli Yella Reddy


 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovation and Impact: The Journey of Inventor Nelli Yella Reddy

Introduction: Nelli Yella Reddy is a prominent inventor based in Hyderabad, Telangana, India. With a commitment to advancing healthcare, she has made significant contributions through her innovative work in the field of pharmaceuticals. Her focus on antiviral compounds positions her as a noteworthy figure in the scientific community.

Latest Patents: Nelli Yella Reddy holds a patent for "Lupeol-type triterpene derivatives as antivirals." This invention revolves around novel lupeol-type triterpene derivatives and related compounds, which are pharmaceutical compositions designed for the therapeutic treatment of viral diseases, with a particular emphasis on HIV-mediated diseases. This patent reflects her dedication to addressing critical health challenges.

Career Highlights: Nelli has cultivated her expertise while working with the Hetero Research Foundation, a subsidiary of Hetero Drugs Limited. Her research and inventions emphasize her commitment to finding effective solutions for viral infections. The success of her patent speaks to her innovative approach and the potential impact of her work in the medical field.

Collaborations: Throughout her career, Nelli has collaborated with talented individuals, including Bandi Parthasaradhi Reddy and Vedula Manohar Sharma. These partnerships have contributed to her research efforts and have allowed for the sharing of diverse ideas and knowledge in the realm of viral therapeutics.

Conclusion: Nelli Yella Reddy's journey as an inventor reflects her passion for innovation and her drive to develop effective antiviral treatments. Her contributions to the field, particularly through her patented work, underscore the importance of research and collaboration in advancing healthcare solutions. As she continues her work at Hetero Research Foundation, the future looks bright for her ongoing contributions to pharmaceutical innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…